NYSEAMERICAN:XXII - 22nd Century Group Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.73 -0.11 (-3.87 %)
(As of 11/19/2018 12:38 PM ET)
Previous Close$2.84
Today's Range$2.67 - $2.83
52-Week Range$1.92 - $4.44
Volume45,071 shs
Average Volume2.46 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

Receive XXII News and Ratings via Email

Sign-up to receive the latest news and ratings for XXII and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryCannabis
SectorMedical
Current SymbolNYSEAMERICAN:XXII
Previous SymbolAMEX:XXII
CUSIPN/A
Phone+1-716-2701523

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees79
Outstanding Shares124,400,000
Market Cap$0.00
OptionableOptionable

22nd Century Group (NYSEAMERICAN:XXII) Frequently Asked Questions

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XXII."

How were 22nd Century Group's earnings last quarter?

22nd Century Group Inc (NYSEAMERICAN:XXII) posted its quarterly earnings results on Wednesday, November, 7th. The biotechnology company reported $0.04 earnings per share for the quarter. The biotechnology company earned $6.26 million during the quarter. View 22nd Century Group's Earnings History.

When is 22nd Century Group's next earnings date?

22nd Century Group is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for 22nd Century Group.

What price target have analysts set for XXII?

1 Wall Street analysts have issued twelve-month target prices for 22nd Century Group's shares. Their predictions range from $11.50 to $11.50. On average, they expect 22nd Century Group's share price to reach $11.50 in the next year. This suggests a possible upside of 321.2% from the stock's current price. View Analyst Price Targets for 22nd Century Group.

What is the consensus analysts' recommendation for 22nd Century Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for 22nd Century Group.

Has 22nd Century Group been receiving favorable news coverage?

News coverage about XXII stock has been trending very positive recently, according to InfoTrie. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. 22nd Century Group earned a media sentiment score of 3.1 on InfoTrie's scale. They also gave news coverage about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future.

Are investors shorting 22nd Century Group?

22nd Century Group saw a decline in short interest during the month of October. As of October 31st, there was short interest totalling 17,609,884 shares, a decline of 2.0% from the October 15th total of 17,964,070 shares. Based on an average daily trading volume, of 2,342,610 shares, the short-interest ratio is currently 7.5 days. Currently, 16.2% of the company's shares are sold short. View 22nd Century Group's Current Options Chain.

Who are some of 22nd Century Group's key competitors?

Who are 22nd Century Group's key executives?

22nd Century Group's management team includes the folowing people:
  • Mr. Henry Sicignano III, Pres, CEO & Director (Age 50)
  • Mr. John T. Brodfuehrer, CFO & Treasurer (Age 60)
  • Mr. Thomas L. James Esq., VP, Gen. Counsel & Sec. (Age 59)
  • James Vail, Director of Communications
  • Dr. Paul J. Rushton, VP of Plant Biotechnology (Age 55)

Who are 22nd Century Group's major shareholders?

22nd Century Group's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.40%), Sandler Capital Management (0.92%), Courier Capital LLC (0.29%), Wells Fargo & Company MN (0.21%), Teachers Advisors LLC (0.20%) and TIAA CREF Investment Management LLC (0.18%). Company insiders that own 22nd Century Group stock include Michael Robert Moynihan and Thomas L James. View Institutional Ownership Trends for 22nd Century Group.

Which institutional investors are selling 22nd Century Group stock?

XXII stock was sold by a variety of institutional investors in the last quarter, including TIAA CREF Investment Management LLC, Creative Planning and AQR Capital Management LLC. View Insider Buying and Selling for 22nd Century Group.

Which institutional investors are buying 22nd Century Group stock?

XXII stock was acquired by a variety of institutional investors in the last quarter, including Sandler Capital Management, BlackRock Inc., Courier Capital LLC, Dimensional Fund Advisors LP, Virtu Financial LLC, Wells Fargo & Company MN and Teachers Advisors LLC. View Insider Buying and Selling for 22nd Century Group.

How do I buy shares of 22nd Century Group?

Shares of XXII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 22nd Century Group's stock price today?

One share of XXII stock can currently be purchased for approximately $2.73.

What is 22nd Century Group's official website?

The official website for 22nd Century Group is http://www.xxiicentury.com/.

How can I contact 22nd Century Group?

22nd Century Group's mailing address is 9530 Main St, CLARENCE, NY 14031-1915, United States. The biotechnology company can be reached via phone at +1-716-2701523.


MarketBeat Community Rating for 22nd Century Group (NYSEAMERICAN XXII)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  224 (Vote Outperform)
Underperform Votes:  197 (Vote Underperform)
Total Votes:  421
MarketBeat's community ratings are surveys of what our community members think about 22nd Century Group and other stocks. Vote "Outperform" if you believe XXII will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XXII will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel